• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK Archive

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view current FDA-TRACK performance measures and projects view the Active Index

Filter








Results

Number of results: 23

ItemProgramOfficeFY
Completed
Strategic PlanStrategic Goal/Area
1Strategic Human Capital Plan ProjectCVMOffice of Management2011N/AN/A
2Resource Planning for Foods Program ProjectCVMOffice of Management2011N/AN/A
3Total number of training events offered during the monthCVMOffice of Management2010N/AN/A
4Total percentage of OM employees who attended training events during the monthCVMOffice of Management2010N/AN/A
5Percentage of CVM employees who reported 100% of their time during the reporting periodCVMOffice of Management2010N/AN/A
6Competency Models ProjectCVMOffice of Management2010N/AN/A
7Workforce Initiative Planning Strategies Project - Workforce ProfilesCVMOffice of Management2010N/AN/A
8Workforce Initiative Planning Strategies Project - Attrition Projection ModelsCVMOffice of Management2010N/AN/A
9Pioneer and Generic Animal Drug User Fees RenegotiationsCVMOffice of Management2013N/AN/A
10Number of pre-AGDUFA generic new animal drug submissions reviewed and completed during the monthCVMOffice of New Animal Drug Evaluation2010N/AN/A
11Number of pending pre-AGDUFA submissions to review at the end of the monthCVMOffice of New Animal Drug Evaluation2010N/AN/A
12Nanotechnology Project - Develop Policies and ProceduresCVMOffice of New Animal Drug Evaluation2010N/AN/A
13Total number of training events offered during the monthCVMOffice of New Animal Drug Evaluation and Office of Minor Use and Minor Species Animal Drug Development2010N/AN/A
14Total percentage of ONADE and OMUMS employees who attended training events during the monthCVMOffice of New Animal Drug Evaluation and Office of Minor Use and Minor Species Animal Drug Development2010N/AN/A
15Integrated Techniques, Approaches, and Technologies for the Characterization of Genomic and Proteomic Biomarkers Measures – Development of techniques to analyze biological specimens for biomarkers of disease or therapeutic responseCVMOffice of Research2013N/AN/A
16NARMS Measures - Develop better molecular techniques for the characterization of isolates in foodborne pathogensCVMOffice of Research2014N/AN/A
17NARMS Data Management Systems ProjectCVMOffice of Research2012N/AN/A
18Total number of training events offered during the monthCVMOffice of Research2010N/AN/A
19Total percentage of OR employees who attended training events during the monthCVMOffice of Research2010N/AN/A
20ADE Reports System ProjectCVMOffice of Surveillance and Compliance2010N/AN/A
21MNVP ProjectCVMOffice of Surveillance and Compliance2012N/AN/A
22Total number of training events during the monthCVMOffice of Surveillance and Compliance2010N/AN/A
23Total percentage of OSC employees who attended training events during the monthCVMOffice of Surveillance and Compliance2010N/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.